Addition of montelukast to low-dose inhaled corticosteroid leads to fewer exacerbations in older patients than medium-dose inhaled corticosteroid monotherapy
PRANA group
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Addition of montelukast to low-dose inhaled corticosteroid leads to fewer exacerbations in older patients than medium-dose inhaled corticosteroid monotherapy'. Together they form a unique fingerprint.